CD177: A member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera

Journal of Translational Medicine

Volumn 2, Issue , 2004, Pages

  Stroncek, David F ^a   Caruccio, Lorraine ^a   Bettinotti, Maria ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

CD177; Myelopoiesis; NB1; Neutrophils; Polycythemia vera; PRV 1

Indexed keywords

BIOCHEMICAL MARKER; CD177 ANTIGEN; CYSTEINE; GLYCOPROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN; MESSENGER RNA; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; DIAGNOSTIC TEST; DNA POLYMORPHISM; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC CODE; GENETIC CONSERVATION; GENETIC IDENTIFICATION; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MULTIGENE FAMILY; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL CHEMOTAXIS; PATHOGENESIS; POLYCYTHEMIA VERA; PROTEIN DOMAIN; REVIEW;

EID: 4344575870     PISSN: 14795876     EISSN: None     Source Type: Journal    
DOI: 10.1186/1479-5876-2-8     Document Type: Review

References (58)

1. Lalezari P, Murphy GB, Allen Jr FH: NB1, a new neutrophil-specific antigen involved in the pathogenesis of neonatal neutropenia. J Clin Invest 1971, 50:1108-1115.
2. Bux J, Bierling P, von dem Borne Kr AEG, et al.: ISBT Granulocyte Antigen Working Party. Nomenclature of Granulocyte Alloantigens. Vox Sang 1999, 77:251.
3. Mason D, Andre P, Bensussan A, Buckley C, Civin C, Clark E, de Haas M, Goyert S, Hadam M, Hart D, Horejsi V, Meuer S, Morrissey J, Schwartz-Albiez R, Shaw S, Simmons D, Uguccioni M, van der Schoot E, Vivier E, Zola H: CD antigens 2002. Blood 2002, 99:3877-3880.
4. Kissel K, Santoso S, Hofmann C, Stroncek D, Bux J: Molecular basis of the neutrophil glycoprotein NB1 (CD177) involved in the pathogenesis of immune neutropenias and transfusion reactions. European Journal of Immunology 2001, 31:1301-1309.
5. Temerinac S, Klippel S, Strunck E, Roder S, Lubbert M, Lange W, Azemar M, Meinhardt G, Schaefer HE, Pahl HL: Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood 2000, 95:2569-2576.
6. Bettinotti MP, Olsen A, Stroncek D: The Use of Bioinformatics to Identify the Genomic Structure of the Gene that Encodes Neutrophil Antigen NB1, CD177. Clinical Immunology 2002, 102:138-144.
7. Caruccio L, Walkovich K, Bettinotti M, Schuller R, Stroncek D: CD177 polymorphisms: correlation between high frequency single nucleotide polymorphisms and neutrophil surface protein expression. Transfusion 2004, 44:77-82.
8. Caruccio L, Bettinotti M, Fraser E, Director-Myska A, Arthur DC, Stroncek DF: PRV-1 and NB1 are alleles of a single gene, CD177, at region 19q13.2 and PRV-1 is the most common allele in a normal population. Blood 2003, 102:661a.
9. Stroncek DF, Skubitz KM, McCullough J: Biochemical nature of the neutrophil-specific antigen NB1. Blood 1990, 75:744-755.
10. Goldschmeding R, van Dalen CM, Faber N, Calafat J, Huizinga TWJ, van der Schoot CE, Clement LT, von dem Borne Kr AEG: Further characterization of the NB1 antigen as a variably expressed 56 - 62 kD GPI linked glycoprotein of plasma membranes and specific granules of neutrophils. Br J Haematol 1992, 81:336-345.
11. Stroncek DF, Shankar R, Litz C, Clement L: The expression of the NB1 antigen on myeloid precursors and neutrophils from children and umbilical cords. Transfusion Medicine 1998, 8:119-123.
12. Stroncek DF, Shankar RA, Noren PA, Herr GP, Clement LT: Analysis of the expression of NB1 antigen using two monoclonal antibodies. Transfusion 1996, 36:168-174.
13. Matsuo K, Lin A, Procter JL, Clement L, Stroncek DF: Variations in the expression of granulocyte antigen NB1. Transfusion 2000, 40:654-662.
14. Caruccio L, Bettinotti M, Matsuo K, Sharon V, Stroncek D: Expression of neutrophil-specific antigen HNA-2a (NB1) is increased in pregnancy. Transfusion 2003, 43:357-363.
15. Stroncek DF, Jaszcz W, Herr G, Clay ME, McCullough J: Expression of neutrophil antigens after 10 days of granulocyte colony-stimulating factor. Transfusion 1998, 38:663-668.
16. Wolff J, Brendel C, Fink L, Bohle RM, Kissel K, Bux J: Lack of NB1 GP (CD177/HNA-2a) gene transcription in NB1 GP-neutrophils from NB1 GP-expressing individuals and association of low expression with NB1 gene polymorphisms. Blood 2003, 102:731-733.
17. Taniguchi K, Kobayashi M, Harada H, Hiraoka A, Tanihiro M, Takata N, Kimura A: Human neutrophil antigen-2a expression on neutrophils from healthy adults in western Japan. Transfusion 2002, 42:651-657.
18. Bierling P, Poulet E, Fromont P, Seror T, Bracq C, Duedari N: Neutrophil-specific antigen and gene frequencies in the French population (letter). Transfusion 1990, 30:848-849.
19. Kissel K, Scheffler S, Kerowgan M, Bux J: Molecular basis of NB1 (HNA-2a, CD177) deficiency. Blood 2002, 99:4231-4233.
20. Bux J, Goehring K, Wolff J, Kissel Karen, Doppl W, Schmidt KL, Fenchel K, Pralle H, Sibelius U: Expression of NB1 glycoprotein (HNA-2a, CD177) on neutrophils is upregulated in inflammatory diseases and during G-CSF expression. Blood 2002, 100:462a.
21. Stroncek DF, Shankar RA, Plachta LB, Clay ME, Dalmasso AP: Polyclonal antibodies against NB1-bearing 58 - 64 kDa glycoprotein of human neutrophils do not identify an NB2-bearing molecule. Transfusion 1993, 33:399-404.
22. Plesner T, Behrendt N, Ploug M: Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Stem Cells 1997, 15:398-408.
23. Spivak JL: Polycythemia vera: myths, mechanisms, and management. Blood 2002, 100:4272-4290.
24. Pahl HL: Towards a molecular understanding of polycythemia rubra vera. Eur J Biochem 2000, 267:3395-3401.
25. Tefferi A: Polycythemia vera: a comprehensive review and clinical recommendations. Mayo Clin Proc 2003, 78:174-194.
26. Kralovics R, Buser AS, Teo SS, Coers J, Tichelli A, van der Maas AP, Skoda RC: Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders. Blood 2003, 102:1869-1871.
27. Klippel S, Strunck E, Temerinac S, Bench AJ, Meinhardt G, Mohr U, Leichtle R, Green AR, Griesshammer M, Heimpel H, Pahl HL: Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis. Blood 2003, 102:3569-3574.
28. Fruehauf S, Topaly J, Villalobos M, Veldwijk MR, Laufs S, Ho AD: Quantitative real-time polymerase chain reaction shows that treatment with interferon reduces the initially upregulated PRV-1 expression in polycythemia vera patients. Haematologica 2003, 88:349-351.
29. Liu E, Jelinek J, Pastore YD, Guan Y, Prchal JF, Prchal JT: Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood 2003, 101:3294-3301.
30. Johansson P, Andreasson B, Safai-Kutti S, Wennstrom L, Palmqvist L, Ricksten A, Lindstedt G, Kutti J: The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia. Eur J Haematol 2003, 70:358-362.
31. Teofili L, Martini M, Luongo M, Di Mario A, Leone G, De Stefano V, Larocca LM: Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia. J Clin Oncol 2002, 20:4249-4254.
32. Johansson P, Ricksten A, Wennstrom L, Palmqvist L, Kutti J, Andreasson B: Increased risk for vascular complications in PRV-1 positive patients with essential thrombocythaemia. Br J Haematol 2003, 123:513-516.
33. Najfeld V, Fuchs S, Merando P, Lezon-Geyda K, Fruchtman S: Fluorescence in situ hybridization analysis of the PRV-1 gene in polycythemia vera: implications for its role in diagnosis and pathogenesis. Exp Hematol 2003, 31:118-121.
34. Klippel S, Strunck E, Busse CE, Behringer D, Pahl HL: Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera. Blood 2002, 100:2441-2448.
35. Spangrude GJ, Aihara Y, Weissman IL, Klein J: The stem cell antigens Sca-1 and Sca-2 subdivide thymic and peripheral T lymphocytes into unique subsets. J Immunol 1988, 141:3697-3707.
36. van de Rijn M, Heimfeld S, Spangrude GJ, Weissman IL: Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc Natl Acad Sci U S A 1989, 86:4634-4638.
37. Classon BJ, Coverdale L: Mouse stem cell antigen Sca-2 is a member of the Ly-6 family of cell surface proteins. Proc Natl Acad Sci U S A 1994, 91:5296-5300.
38. Capone MC, Gorman DM, Ching EP, Zlotnik A: Identification through bioinformatics of cDNAs encoding human thymic shared Ag-1/stem cell Ag-2. A new member of the human Ly-6 family. J Immunol 1996, 157:969-973.
39. Petranka JG, Fleenor DE, Sykes K, Kaufman RE, Rosse WF: Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein. Proc Natl Acad Sci U S A 1992, 89:7876-7879.
40. Bickmore WA, Longbottom D, Oghene K, Fletcher JM, van Heyningen V: Colocalization of the human CD59 gene to 11p13 with the MIC11 cell surface antigen. Genomics 1993, 17:129-135.
41. Shetty J, Wolkowicz MJ, Digilio LC, Klotz KL, Jayes FL, Diekman AB, Westbrook VA, Farris EM, Hao Z, Coonrod SA, Flickinger CJ, Herr JC: SAMP14, a novel, acrosomal membrane-associated, glycosylphosphatidylinositol-anchored member of the Ly-6/urokinase-type plasminogen activator receptor superfamily with a role in sperm-egg interaction. J Biol Chem 2003, 278:30506-30515.
42. Jalkut MW, Reiter RE: Role of prostate stem cell antigen in prostate cancer research. Curr Opin Urol 2002, 12:401-406.
43. Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON: Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci U S A 1998, 95:1735-1740.
44. Mao M, Yu M, Tong JH, Ye J, Zhu J, Huang QH, Fu G, Yu L, Zhao SY, Waxman S, Lanotte M, Wang ZY, Tan JZ, Chan SJ, Chen Z: RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. Proc Natl Acad Sci U S A 1996, 93:5910-5914.
45. Kimura Y, Furuhata T, Urano T, Hirata K, Nakamura Y, Tokino T: Genomic structure and chromosomal localization of GML (GPI-anchored molecule-like protein), a gene induced by p53. Genomics 1997, 41:477-480.
46. Horie M, Okutomi K, Taniguchi Y, Ohbuchi Y, Suzuki M, Takahashi E: Isolation and characterization of a new member of the human Ly6 gene family (LY6H). Genomics 1998, 53:365-368.
47. Brakenhoff RH, Gerretsen M, Knippels EM, van Dijk M, van Essen H, Weghuis DO, Sinke RJ, Snow GB, van Dongen GA: The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion. J Cell Biol 1995, 129:1677-1689.
48. de Nooij-van Dalen AG, van Dongen GA, Smeets SJ, Nieuwenhuis EJ, Stigter-van Walsum M, Snow GB, Brakenhoff RH: Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma. Int J Cancer 2003, 103:768-774.
49. Chimienti F, Hogg RC, Plantard L, Lehmann C, Brakch N, Fischer J, Huber M, Bertrand D, Hohl D: Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Hum Mol Genet 2003, 12:3017-3024.
50. Fischer J, Bouadjar B, Heilig R, Huber M, Lefevre C, Jobard F, Macari F, Bakija-Konsuo A, Ait-Belkacem F, Weissenbach J, Lathrop M, Hohl D, Prud'homme JF: Mutations in the gene encoding SLURP-1 in Mal de Meleda. Hum Mol Genet 2001, 10:875-880.
51. Tsuji H, Okamoto K, Matsuzaka Y, Iizuka H, Tamiya G, Inoko H: SLURP-2, a novel member of the human Ly-6 superfamily that is up-regulated in psoriasis vulgaris. Genomics 2003, 81:26-33.
52. Mallya M, Campbell RD, Aguado B: Transcriptional analysis of a novel cluster of LY-6 family members in the human and mouse major histocompatibility complex: five genes with many splice forms. Genomics 2002, 80:113-123.
53. Palfree RG: Ly-6-domain proteins - new insights and new members: a C-terminal Ly-6 domain in sperm acrosomal protein SP-10. Tissue Antigens 1996, 48:71-79.
54. Freemerman AJ, Flickinger CJ, Herr JC: Characterization of alternatively spliced human SP-10 mRNAs. Mol Reprod Dev 1995, 41:100-98.
55. Pearson TC, Messinezy M, Westwood N, Green AR, Bench AJ, Huntly BJP, Nacheva EP, Tiziano B, Finazzi G: A polycythemia vera update: diagnosis, pathobiology, and treatment. Hematology 2000, 51-68.
56. Dinauer MC, Lekstrom-Himes JA, Dale DC: Inherited Neutrophil Disorders: Molecular Basis and New Therapies. Hematology (Am Soc Hematol Educ Program) 2000, 303-318.
57. Uzel G, Holland SM: White blood cell defects: molecular discoveries and clinical management. Curr Allergy Asthma Rep 2002, 2:385-391.
58. Horwitz M, Benson KF, Duan Z, Person RE, Wechsler J, Williams K, Albani D, Li FQ: Role of neutrophil elastase in bone marrow failure syndromes:molecular genetic revival of the chalone hypothesis. Curr Opin Hematol 2003, 10:49-54.